Cargando…
Clinical outcomes and lung toxicities after lung SABR using dynamic conformal arc therapy: a single-institution cohort study
BACKGROUND: Stereotactic ablative radiotherapy (SABR) is a validated treatment for early stage lung cancer and pulmonary metastases. It provides a high local control rate with low symptomatic toxicities. Recently, Dynamic Conformal Arc Therapy (DCAT), a delivery option that differs from conventional...
Autores principales: | Mesny, Emmanuel, Ayadi, Myriam, Dupuis, Pauline, Beldjoudi, Guillaume, Tanguy, Ronan, Martel-Lafay, Isabelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9948312/ https://www.ncbi.nlm.nih.gov/pubmed/36814265 http://dx.doi.org/10.1186/s13014-023-02227-2 |
Ejemplares similares
-
Harmonization of dose prescription for lung stereotactic radiotherapy
por: Beldjoudi, Guillaume, et al.
Publicado: (2022) -
Volumetric modulated arc therapy (VMAT) comparison to 3D‐conformal technique in lung stereotactic ablative radiotherapy (SABR)
por: Mark, Frances, et al.
Publicado: (2022) -
Pneumomediastinum as a complication of SABR for lung metastases
por: Rodríguez-Ruiz, María Esperanza, et al.
Publicado: (2015) -
Vestibular Schwannoma: Results of Hypofractionated Stereotactic Radiation Therapy
por: Pialat, Pierre-Marie, et al.
Publicado: (2021) -
Evaluation of tumour motion and internal/external correlation in lung SABR
por: Ali, Asmaa M, et al.
Publicado: (2023)